Literature DB >> 1098888

[Fludrocortisone in the treatment of orthostatic hypotension: ophthalmodynamography during standing(author's transl)].

J Finke, I Sagemüller.   

Abstract

The effect of fludrocortisone (Astonin -H) in the management of orthostatic hypotension was tested in a double-blind trial of 30 patients who were receiving 0.3 mg fludrocortisone for seven days, a control group of 30 subjects receiving placebos. Systolic and diastolic brachial and ophthalmic arterial pressures, pulse amplitude and pulse rate were measured at rest, immediately after standing up and 10 minutes later. Comparing the treatment and placebo groups, the former had a higher systolic ophthalmic blood pressure on standing, a smaller fall of pulse volume and less of a rise in heart rate on standing up, and a raised systolic brachial artery pressure even in recumbency. At the same time there was an improvement in symptoms.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1098888     DOI: 10.1055/s-0028-1106461

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  5 in total

1.  Guidelines for the diagnosis and management of syncope (version 2009).

Authors:  Angel Moya; Richard Sutton; Fabrizio Ammirati; Jean-Jacques Blanc; Michele Brignole; Johannes B Dahm; Jean-Claude Deharo; Jacek Gajek; Knut Gjesdal; Andrew Krahn; Martial Massin; Mauro Pepi; Thomas Pezawas; Ricardo Ruiz Granell; Francois Sarasin; Andrea Ungar; J Gert van Dijk; Edmond P Walma; Wouter Wieling
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

2.  Advances in syncope: with emphasis on reflex syncope.

Authors:  John D Fisher
Journal:  J Interv Card Electrophysiol       Date:  2011-06-07       Impact factor: 1.900

3.  [Treatment of syncope].

Authors:  D Andresen
Journal:  Herz       Date:  2014-06       Impact factor: 1.443

Review 4.  Orthostatic hypotension: From pathophysiology to clinical applications and therapeutic considerations.

Authors:  Nikolaos Magkas; Costas Tsioufis; Costas Thomopoulos; Polychronis Dilaveris; Georgios Georgiopoulos; Elias Sanidas; Vasilios Papademetriou; Dimitrios Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-03-22       Impact factor: 3.738

5.  Fludrocortisone for orthostatic hypotension.

Authors:  Stephanie Veazie; Kim Peterson; Yasmin Ansari; Kathryn A Chung; Christopher H Gibbons; Satish R Raj; Mark Helfand
Journal:  Cochrane Database Syst Rev       Date:  2021-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.